Lanreotide | Somatuline® Depot (injection) (Tercica) | Long-term treatment of acromegalic patients who have had an inadequate response to or cannot be treated with surgery and/or radiotherapy | Drug Information Portal
|
Octreotide | Sandostatin LAR (Novartis Pharmaceuticals Corporation) | Reduction of growth hormone and IGF-1 (somatomedin C) in acromegaly. | Drug Information Portal
MedlinePlus |
Pegvisomant | Somavert® (Pfizer) | Treatment of acromegaly in patients who have had an inadequate response to surgery and/or radiation therapy and/or other medical therapies, or for whom these therapies are not appropriate | Drug Information Portal
|